Rwanda has acquired its first modular container prototype known as BioNTainers which uses mRNA technology to produce vaccines.
"Historic milestone today as the first BioNtainers arrived in Rwanda, exactly 3 years since the first case of Covid-19 was detected in our country. This system will allow end-to-end mRNA vaccine production in Africa for the first time," said Rwandan President Paul Kagame in a tweet posted on Monday.
The BioNTainers are expected to commence manufacturing vaccines approximately 12 to 18 months after their installation.
Historic milestone today as the first @BioNTech_Group BioNTainers arrived in Rwanda, exactly 3 years since the first case of Covid-19 was detected in our country. This system will allow end-to-end mRNA vaccine production in Africa for the first time.